Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 80, Issue 3, Pages 471-478Publisher
WILEY
DOI: 10.1189/jlb.0206094
Keywords
cytotoxic T lymphocytes; NK cells; tumor immunotherapy; clinical trial
Categories
Ask authors/readers for more resources
Exosomes are nanometer-sized membrane vesicles invaginating from multivesicular bodies and secreted from different cell types. They represent an in vitro discovery, but vesicles with the hallmarks of exosomes are present in vivo in germinal centers and biological fluids. Their protein and lipid composition is unique and could account for their expanding functions such as eradication of obsolete proteins, antigen presentation, or Trojan horses for viruses or prions. The potential of dendritic cell-derived exosomes (Dex) as cell-free cancer vaccines is addressed in this review. Lessons learned from the pioneering clinical trials allowed reassessment of the priming capacities of Dex in preclinical models, optimizing clinical protocols, and delineating novel, biological features of Dex in cancer patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available